A detailed history of Dupont Capital Management Corp transactions in Boston Scientific Corp stock. As of the latest transaction made, Dupont Capital Management Corp holds 143,437 shares of BSX stock, worth $13 Million. This represents 1.02% of its overall portfolio holdings.

Number of Shares
143,437
Previous 168,810 15.03%
Holding current value
$13 Million
Previous $13 Million 7.54%
% of portfolio
1.02%
Previous 1.14%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$72.96 - $84.0 $1.85 Million - $2.13 Million
-25,373 Reduced 15.03%
143,437 $12 Million
Q2 2024

Jul 18, 2024

SELL
$67.33 - $77.71 $2.17 Million - $2.51 Million
-32,265 Reduced 16.05%
168,810 $13 Million
Q1 2024

Apr 23, 2024

SELL
$57.6 - $68.62 $1.85 Million - $2.2 Million
-32,095 Reduced 13.76%
201,075 $13.8 Million
Q4 2023

Jan 23, 2024

SELL
$48.64 - $57.81 $3.79 Million - $4.51 Million
-77,941 Reduced 25.05%
233,170 $13.5 Million
Q3 2023

Oct 27, 2023

BUY
$50.19 - $54.68 $8.96 Million - $9.76 Million
178,488 Added 134.58%
311,111 $16.4 Million
Q2 2023

Jul 25, 2023

BUY
$49.72 - $54.64 $1.03 Million - $1.13 Million
20,705 Added 18.5%
132,623 $7.17 Million
Q1 2023

Apr 28, 2023

BUY
$45.09 - $50.03 $1.04 Million - $1.15 Million
23,065 Added 25.96%
111,918 $5.6 Million
Q4 2022

Jan 26, 2023

BUY
$39.56 - $47.22 $728,932 - $870,075
18,426 Added 26.16%
88,853 $0
Q3 2022

Oct 31, 2022

SELL
$36.71 - $109.66 $1.85 Million - $5.54 Million
-50,518 Reduced 41.77%
70,427 $2.73 Million
Q2 2022

Jul 26, 2022

SELL
$35.24 - $47.1 $683,691 - $913,787
-19,401 Reduced 13.82%
120,945 $4.51 Million
Q1 2022

Apr 27, 2022

SELL
$40.9 - $45.1 $484,378 - $534,119
-11,843 Reduced 7.78%
140,346 $6.22 Million
Q4 2021

Jan 31, 2022

SELL
$38.07 - $44.87 $1.56 Million - $1.84 Million
-41,094 Reduced 21.26%
152,189 $6.47 Million
Q3 2021

Nov 03, 2021

SELL
$41.23 - $45.88 $2.26 Million - $2.51 Million
-54,736 Reduced 22.07%
193,283 $8.39 Million
Q2 2021

Jul 30, 2021

BUY
$38.58 - $44.24 $3 Million - $3.45 Million
77,878 Added 45.77%
248,019 $10.6 Million
Q1 2021

Apr 29, 2021

SELL
$35.27 - $39.67 $1.66 Million - $1.86 Million
-46,948 Reduced 21.63%
170,141 $6.58 Million
Q4 2020

Jan 28, 2021

SELL
$33.15 - $41.97 $300,305 - $380,206
-9,059 Reduced 4.01%
217,089 $7.8 Million
Q3 2020

Oct 29, 2020

SELL
$34.44 - $42.23 $520,181 - $637,841
-15,104 Reduced 6.26%
226,148 $8.64 Million
Q2 2020

Jul 24, 2020

BUY
$30.19 - $39.11 $5.09 Million - $6.59 Million
168,516 Added 231.68%
241,252 $8.47 Million
Q1 2020

Apr 29, 2020

BUY
$25.83 - $45.71 $43,032 - $76,152
1,666 Added 2.34%
72,736 $2.37 Million
Q4 2019

Jan 27, 2020

SELL
$37.87 - $45.37 $620,765 - $743,705
-16,392 Reduced 18.74%
71,070 $3.21 Million
Q3 2019

Oct 28, 2019

BUY
$40.31 - $43.45 $440,427 - $474,734
10,926 Added 14.28%
87,462 $3.56 Million
Q2 2019

Jul 30, 2019

SELL
$34.91 - $42.98 $2.02 Million - $2.49 Million
-57,829 Reduced 43.04%
76,536 $3.29 Million
Q1 2019

Apr 30, 2019

SELL
$32.91 - $40.75 $611,467 - $757,135
-18,580 Reduced 12.15%
134,365 $5.16 Million
Q4 2018

Feb 01, 2019

BUY
$31.73 - $39.04 $25,637 - $31,544
808 Added 0.53%
152,945 $5.41 Million
Q3 2018

Nov 05, 2018

SELL
$32.83 - $38.63 $498,195 - $586,210
-15,175 Reduced 9.07%
152,137 $5.86 Million
Q2 2018

Jul 30, 2018

BUY
$26.84 - $34.32 $96,731 - $123,689
3,604 Added 2.2%
167,312 $5.47 Million
Q1 2018

May 02, 2018

BUY
$25.2 - $28.54 $3.63 Million - $4.12 Million
144,196 Added 739.01%
163,708 $4.47 Million
Q4 2017

Jan 31, 2018

BUY
$24.79 - $29.8 $265,600 - $319,277
10,714 Added 121.78%
19,512 $484,000
Q3 2017

Oct 31, 2017

BUY
$26.26 - $29.17 $231,035 - $256,637
8,798
8,798 $257,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Dupont Capital Management Corp Portfolio

Follow Dupont Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.